Published in
Springer (part of Springer Nature), Targeted Oncology, 6(12), p. 815-826
DOI: 10.1007/s11523-017-0528-z
Links
Tools
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Journal article published in 2017 by
Anke E. M. van Erp 
,
Laurens van Houdt,
Winette T. A. van der Graaf,
Melissa H. S. Hillebrandt-Roeffen,
Emmy D. G. Fleuren ,
Yvonne M. H. Versleijen-Jonkers
,
Laurens van Houdt,
Winette T. A. van der Graaf,
Melissa H. S. Hillebrandt-Roeffen,
Emmy D. G. Fleuren ,
Yvonne M. H. Versleijen-Jonkers
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 